Published in Bioorg Khim on April 01, 1999
Suppression of influenza virus replication in infected mice by protease inhibitors. J Gen Virol (1984) 1.17
Two forms of influenza virus nucleoprotein in infected cells and virions. Virology (1981) 1.15
Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses. Arch Virol (2005) 1.11
The in situ spatial arrangement of the influenza A virus matrix protein M1 assessed by tritium bombardment. Proc Natl Acad Sci U S A (1999) 0.95
A modified plaque assay method for accurate analysis of infectivity of influenza viruses with uncleaved hemagglutinin. Arch Virol (1982) 0.94
Protein synthesis in Sendai virus-infected cells. J Gen Virol (1975) 0.93
Myxovirus replication in chicken embryos can be suppressed by aprotinin due to the blockage of viral glycoprotein cleavage. J Gen Virol (1985) 0.92
High protection of animals lethally infected with influenza virus by aprotinin-rimantadine combination. J Med Virol (1987) 0.86
Protective effect of protease inhibitors in influenza virus infected animals. Arch Virol (1982) 0.86
Proteolytic activation of influenza WSN virus in cultured cells is performed by homologous plasma enzymes. J Gen Virol (1982) 0.85
Aprotinin aerosol treatment of influenza and paramyxovirus bronchopneumonia of mice. Antiviral Res (1994) 0.84
Prime-boost vaccination with a combination of proteosome-degradable and wild-type forms of two influenza proteins leads to augmented CTL response. Vaccine (2008) 0.83
Deoxycholate-mediated cleavage of the protein of Sendai virus nucleocapsid derived from infected cells. Biochem Biophys Res Commun (1974) 0.83
[Integration of influenza A virus NSP gene into baculovirus genome and its expression in insect cells]. Vopr Virusol (2010) 0.83
[Antiviral and therapeutic action of protease inhibitors in viral infections: experimental and clinical observations]. Vopr Virusol (1984) 0.81
Covalent chromatography of influenza virus membrane M1 protein on activated thiopropyl Sepharose-6B. J Chromatogr B Biomed Sci Appl (1998) 0.78
[Interaction of influenza virus matrix protein M1 with histones]. Mol Biol (Mosk) (1997) 0.78
Alphavirus replication in cultured cells and infected animals is inhibited by antiproteinase agents. Antiviral Res (1986) 0.78
[Site-directed modification of caspase cleavage site regions in avian influenza virus proteins]. Vopr Virusol (2009) 0.77
[Pathogenic effect of pandemic influenza virus H1N1 under replication in cultures of human cells]. Vopr Virusol (2013) 0.77
Interaction of hydrophobized antiviral antibodies with influenza virus infected MDCK cells. Biochem Mol Biol Int (1993) 0.77
[Key role of Asp16 in proteolysis of influenza A NP protein by caspases in infected cells]. Vopr Virusol (2004) 0.77
[Localization of the influenza virus M1 matrix protein in the virion]. Mol Biol (Mosk) (2000) 0.77
[The phenomenon of proteolytic activation of myxoviruses and a new strategy for treating viral diseases]. Vopr Virusol (1983) 0.77
[Clinical effectiveness of aprotinin aerosol in influenza and parainfluenza]. Vestn Ross Akad Med Nauk (1996) 0.76
[Enhancement of alphavirus reproduction in cell cultures at an alkaline pH]. Vopr Virusol (1987) 0.76
[Identification of the protease-binding domain in the N-terminal region of the influenza A virus matrix protein M1]. Mol Biol (Mosk) (2001) 0.75
[Aprotinin antiviral aerosol: study of the local irritating and allergenic action after inhalation]. Antibiot Khimioter (1995) 0.75
[The effect of pH on in vitro deproteinization in orthomyxo- and paramyxoviruses]. Mol Gen Mikrobiol Virusol (1990) 0.75
[Protease inhibitors block the spread of the influenza virus in the body of infected animals]. Dokl Akad Nauk SSSR (1983) 0.75
[Influenza A virus M1 matrix protein is similar to protease inhibitors]. Dokl Akad Nauk (1999) 0.75
[Synthesis of virus-specific macromolecules and virion maturation in chick embryo cells infected with Sendai virus]. Vopr Virusol (1976) 0.75
[Improved method of determining the infectivity of the influenza virus]. Vopr Virusol (1981) 0.75
[Aprotinin-induced inhibition of pandemic influenza virus A(H1N1) reproduction]. Vopr Virusol (2011) 0.75
[Inhibition of the reproduction of the influenza B virus by aprotinin]. Vopr Virusol (1992) 0.75
[Evolutionary changes in the NA and HA genes of H3N2 influenza virus in the Moscow Region during 2003-2009]. Vopr Virusol (2011) 0.75
[Electrophoretic analysis of the proteins of different alphavirus strains]. Vopr Virusol (1987) 0.75
[The pathogenetic therapy of acute respiratory diseases by aprotinin inhalations]. Ter Arkh (1995) 0.75
[Molecular mechanisms of proteolytic processing of viral proteins and the problem of antiviral chemotherapy and vaccine design]. Mol Biol (Mosk) (1988) 0.75
[Cleavage of influenza virus hemagglutinin as affected by serum plasmin in cell culture and in vivo]. Vopr Virusol (1982) 0.75
[The antiviral aerosol aprotinin. General effect on the body after inhalation administration]. Antibiot Khimioter (1994) 0.75
[The therapeutic effect of aprotinin inhalations in influenza and paramyxovirus infections in mice]. Vopr Virusol (1993) 0.75
[Blocking of Sindbis virus replication in the body of infected mice using an inhibitor of chymotrypsin-like proteases]. Vopr Virusol (1985) 0.75
[Study of Sendai virus proteins: the proteolytic activity in the composition of the viral particles]. Vopr Virusol (1978) 0.75
[Cell-dependent and strain variations in the nucleocapsid protein P2(PA) of the influenza virus]. Vopr Virusol (1987) 0.75
[Surface localization of amino acids in influenza virus hemagglutinin during functional transformation of virions by acidic pH]. Mol Biol (Mosk) (1996) 0.75
[Characterization of proteolytic cleavage of influenza virus nucleocapsid protein NP in infected cells]. Vopr Virusol (2000) 0.75
[The trypsin cleavage of hemagglutinin enhances the infectivity of the influenza virus in mice]. Vopr Virusol (1990) 0.75
[pH-dependent rearrangements in the influenza A virus]. Vopr Virusol (2014) 0.75
[Identification of monoclonal antibodies against protein E1 of venezuelan equine encephalomyelitis virus blocking the hemagglutinating but not the infective activity of virions]. Mol Gen Mikrobiol Virusol (1985) 0.75
[Alphavirus replication: the cascade proteolytic shearing of virus-specific polyproteins and virion morphogenesis]. Vopr Virusol (1987) 0.75
[Difference in influenza virus strains in the intensity of the proteolytic modification of the base nucleocapsid protein NP56 to NP53 in infected cells]. Vopr Virusol (1983) 0.75
[Suppression of the proteolytic activation of myxoviruses in infected chick embryos by using aprotinin]. Vopr Virusol (1985) 0.75
[Protease inhibitor suppression of influenza virus replication in the lungs of infected mice]. Vopr Virusol (1983) 0.75
[Influenza virus proteins. Incorporation of newly synthesized viral proteins into virions]. Vopr Virusol (1983) 0.75
[Proteolytic cleavage of influenza virus A protein NP characteristic of the strains of human origin detected in various strains isolated from animals]. Mol Gen Mikrobiol Virusol (1986) 0.75
[NP gene of pandemic H1N1 virus attenuates virulence of mouse-adapted human influenza virus]. Vopr Virusol (2011) 0.75
[Proteolytic processing of viral and bacterial proteins and its potentials in controlled modification for vaccine design]. Mol Gen Mikrobiol Virusol (1986) 0.75
The properties of the Sendai virus ribonucleoproteins involved in genome transcription in infected cells. J Gen Virol (1974) 0.75
[Biochemical features of protein matrix M1 of the influenza C virus]. Mol Biol (Mosk) (1993) 0.75
[The anomalous isoelectric properties of influenza virus matrix protein M1]. Vopr Virusol (1991) 0.75
[Influenza virus proteins: preparation of a soluble M1 polypeptide by means of a stepwise deproteination of virions]. Mol Biol (Mosk) (1991) 0.75
[Influenza virus proteins. Subcellular distribution and intracellular transport of de novo synthesized viral proteins in infected cells]. Vopr Virusol (1982) 0.75
[2 forms of influenza virus nucleocapsid protein (NP) in virions and infected cells]. Vopr Virusol (1981) 0.75
[Study of Sendai virus proteins]. Vopr Virusol (1975) 0.75
[Synergic therapeutic action of aprotinin and remantadine in experimental influenzal infection]. Vopr Virusol (1986) 0.75
[Antiviral activity of proteinase inhibitors in cultured cells infected with alpha-viruses]. Mol Gen Mikrobiol Virusol (1985) 0.75
[Intracellular proteolytic cleavage of the influenza virus protein NP as a sign of the epidemicity of virus strains?]. Mol Gen Mikrobiol Virusol (1987) 0.75